These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9859152)

  • 21. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.
    Sterling TR; Chaisson RE; Keruly J; Moore RD
    J Infect Dis; 2003 Dec; 188(11):1659-65. PubMed ID: 14639536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.
    Wilhan ; Budiono E
    Acta Med Indones; 2008 Apr; 40(2):59-62. PubMed ID: 19054881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.
    Gautier D; Beq S; Cortesão CS; Sousa AE; Cheynier R
    J Virol; 2007 Nov; 81(22):12685-8. PubMed ID: 17804512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer in patients infected with the human immunodeficiency virus.
    Leitao MM; White P; Cracchiolo B
    Cancer; 2008 Jun; 112(12):2683-9. PubMed ID: 18438877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
    Casado E; Olivé A; Holgado S; Perez-Andres R; Romeu J; Lorenzo JC; Clotet B; Tena X
    J Rheumatol; 2001 Apr; 28(4):802-4. PubMed ID: 11327254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term study of intraocular pressure changes in patients with human immunodeficiency virus treated with highly active antiretroviral therapy.
    Kozak I; LaBree L; Azen SP; Cheng L; Reagan NL; Freeman WR
    Ophthalmology; 2006 Mar; 113(3):451-5. PubMed ID: 16513459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The F response parameters in Behçet's disease.
    Budak F; Efendi H; Apaydin R; Bilen N; Komsuoglu S
    Electromyogr Clin Neurophysiol; 2000; 40(1):45-8. PubMed ID: 10782357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.
    McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA
    Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central conduction abnormalities after electrical injury.
    Triggs WJ; Owens J; Gilmore RL; Campbell K; Quisling R
    Muscle Nerve; 1994 Sep; 17(9):1068-70. PubMed ID: 8065396
    [No Abstract]   [Full Text] [Related]  

  • 33. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
    Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.
    Aladdin H; Ullum H; Dam Nielsen S; Espersen C; Mathiesen L; Katzenstein TL; Gerstoft J; Skinhoj P; Pedersen BK
    J Infect Dis; 2000 Mar; 181(3):1148-52. PubMed ID: 10720544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.
    Stebbing J; Waters L; Mandalia S; Bower M; Nelson M; Gazzard B
    Clin Infect Dis; 2005 Sep; 41(6):906-11. PubMed ID: 16107994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurological complications of the human immunodeficiency virus (HIV) infection].
    García-Moncó JC; Pinedo Brochado A; Escalza Cortina I
    Neurologia; 2007 Jun; 22(5):312-9. PubMed ID: 17508305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.